The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this approach offers a less invasive way to administer https://brendamsoc131999.blogdemls.com/40764954/glp-1-patches-a-new-approach-to-glucose-control